Literature DB >> 4263796

On the role of central nervous system catecholamines and 5-hydroxytryptamine in the nialamide-induced behavioural syndrome.

K Modigh, T H Svensson.   

Abstract

1. Intraperitoneal administration of nialamide, 200 mg/kg, to mice elicited a pronounced increase in motor activity and rectal temperature concomitant with a gradual increase in the concentrations of 5-hydroxytryptamine (5-HT), noradrenaline (NA) and dopamine in the brain.2. In mice treated with L-tryptophan, 300 mg/kg, 1 h before nialamide, the increase in motor activity appeared earlier than after nialamide alone, and the hyperthermia was more pronounced. The increase in 5-HT concentrations in the brain was more pronounced in these animals, whereas the concentrations of NA and dopamine were of the same magnitude as after nialamide alone.3. Treatment with p-chlorophenylalanine methylester-HCl (PCPA), 400 mg/kg, 24 h before nialamide partially antagonized the increase in motor activity and the accumulation of NA and dopamine was not significantly different from that observed after nialamide alone.4. Treatment with PCPA, 800 mg/kg, 72, 48 and 24 h before nialamide, completely antagonized the increase in motor activity and rectal temperature. The accumulation of brain 5-HT was greatly depressed in these animals. The concentrations of dopamine 1, 3 and 6 h and the concentration of NA 6 h after the nialamide injection were significantly lower in the mice given PCPA 800 mg/kg x 3, than in the mice given nialamide alone.5. Administration of DL-5-hydroxytryptophan, 30 mg/kg, 1 h after the nialamide injection, to mice pretreated with PCPA, 800 mg/kg x 3, restored the increase in motor activity and rectal temperature.6. L-Tryptophan, 300 mg/kg, given 1 h before nialamide to mice pretreated with PCPA, 800 mg/kg x 3, elicited a moderate increase in motor activity and a slight increase in the accumulation of 5-HT in the brain when compared to that after PCPA, 800 mg/kg x 3, and nialamide.7. Administration of alpha-methyltyrosine methylester, 200 mg/kg, 2 h before nialamide partially antagonized the increase in motor activity and completely antagonized the increase in rectal temperature elicited by nialamide alone. The accumulation of brain NA and dopamine was inhibited in these animals.8. It is concluded that the excitation in mice, elicited by nialamide, is mediated largely via brain 5-HT, but that also the brain catecholamines seem to contribute to this effect.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4263796      PMCID: PMC1666113          DOI: 10.1111/j.1476-5381.1972.tb06846.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  EFFECTS ON TEMPERATURE OF AMINES INJECTED INTO THE CEREBRAL VENTRICLES. A NEW CONCEPT OF TEMPERATURE REGULATION.

Authors:  W FELDBERG; R D MYERS
Journal:  J Physiol       Date:  1964-09       Impact factor: 5.182

2.  3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists.

Authors:  A CARLSSON; M LINDQVIST; T MAGNUSSON
Journal:  Nature       Date:  1957-11-30       Impact factor: 49.962

3.  On the role of central noradrenaline in the regulation of motor activity and body temperature in the mouse.

Authors:  T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

Review 4.  Drugs and body temperature.

Authors:  P Lomax
Journal:  Int Rev Neurobiol       Date:  1970       Impact factor: 3.230

5.  An improved method for the fluorimetric determination of 5-hydroxytryptamine in tissues.

Authors:  N E Andén; T Magnusson
Journal:  Acta Physiol Scand       Date:  1967 Jan-Feb

6.  On the significance of central noradrenaline for motor activity: experiments with a new dopamine beta-hydroxylase inhibitor.

Authors:  T H Svensson; B Waldeck
Journal:  Eur J Pharmacol       Date:  1969-09       Impact factor: 4.432

7.  The effects of p-chlorophenylalanine, a serotonin depletor, on avoidance acquisition, pain sensitivity and related behavior in the rat.

Authors:  S S Tenen
Journal:  Psychopharmacologia       Date:  1967

8.  Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin.

Authors:  E Jéquier; W Lovenberg; A Sjoerdsma
Journal:  Mol Pharmacol       Date:  1967-05       Impact factor: 4.436

9.  Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan.

Authors:  D G Grahame-Smith
Journal:  J Neurochem       Date:  1971-06       Impact factor: 5.372

Review 10.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

View more
  10 in total

1.  [Feeding behavior in sheep: effects of nialamide and 6-hydroxydopamine (author's transl)].

Authors:  S Croze; J Bost
Journal:  Psychopharmacologia       Date:  1974

2.  Effects of L-tryptophan on motor activity in mice.

Authors:  K Modigh
Journal:  Psychopharmacologia       Date:  1973-05-21

3.  The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.

Authors:  J J Feigenbaum; J Yanai; H L Klawans
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

4.  Regional cerebral cortical activation in monoamine oxidase A-deficient mice: differential effects of chronic versus acute elevations in serotonin and norepinephrine.

Authors:  D P Holschneider; O U Scremin; L Huynh; K Chen; I Seif; J C Shih
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

5.  Sex differences in behavioral and thermal responses to pargyline and tryptophan.

Authors:  A Biegon; M Segal; D Samuel
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

6.  Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine.

Authors:  J Buus Lassen; J Lund; E Bechgaard; I Søndergaard
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

7.  Behavioural hyperactivity in rats treated with selective monoamine oxidase inhibitors and LM 5008, a selective 5-hydroxytryptamine uptake blocker.

Authors:  R Ashkenazi; J P Finberg; M B Youdim
Journal:  Br J Pharmacol       Date:  1983-07       Impact factor: 8.739

8.  Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats.

Authors:  Zhiyuan Ma; Gongliang Zhang; Chris Jenney; Swapna Krishnamoorthy; Rui Tao
Journal:  Eur J Pharmacol       Date:  2008-04-08       Impact factor: 4.432

9.  Nialamide-induced hypermotility in mice treated with inhibitors of monoamine uptake, 5-HT antagonists and lithium.

Authors:  J Buus Lassen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

10.  Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.

Authors:  J C Pecknold; L Luthe; L Iny; D Ramdoyal
Journal:  J Psychiatry Neurosci       Date:  1995-05       Impact factor: 6.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.